Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced that members of the management team will participate in a fireside chat at the Leerink Partners 2025 Global Healthcare Conference on Tuesday, March 11th at 3:40 p.m. ET.
https://mma.prnewswire.com/media/370141/regulus_logo_finalnew_Logo.jpg
The live event and replay of the presentation will be available under “Events and Presentations” through the investor relations section of the Company's website at https://ir.regulusrx.com/events and archived for 90 days following the presentation date.
About RegulusRegulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in San Diego, CA.
https://c212.net/c/img/favicon.png?sn=LA31999&sd=2025-03-04
View original content to download multimedia:https://www.prnewswire.com/news-releases/regulus-therapeutics-to-present-at-the-leerink-partners-2025-global-healthcare-conference-302390551.html
SOURCE Regulus Therapeutics Inc.
https://rt.newswire.ca/rt.gif?NewsItemId=LA31999&Transmission_Id=202503040800PR_NEWS_USPR_____LA31999&DateId=20250304